Homepage
Greater London
Greater London Legal Chronicle
Grey Wolf Therapeutics’ $49 Million Series B Funding Round

Grey Wolf Therapeutics’ $49 Million Series B Funding Round

February 3, 2023 Martina Bellini Greater London Legal Chronicle

Tagged: Andrew Harrow Anna Ward Chloe Smith DLA Piper Dylan Kennett Earlybird Venture Capital GmbH & Co. KG Goodwin Procter Grey Wolf Therapeutics Jon Kenworthy Kate Black Mary Foord-Weston Pfizer Ventures Richard Bloomfield Richard Taylor Satnam Sahota Tom Watkins

In UK DLA Piper, Goodwin Procter, advised on the matter.DLA Piper advised Earlybird Venture Capital GmbH & Co. KG , Pfizer Ventures with a team including…

This content is for members only.
Login Join Now

PrintFriendly

Author: Martina Bellini

…

This content is for members only.
Login Join Now

PrintFriendly

View all posts by Martina Bellini

Apex Group’s Acquisition of Efficient Group

Berlin Hyp AG, Deutsche Pfandbriefbank AG and Deutsche Bank AG’s €435 Million Refinancing of PBSA Portfolio

Barrett Steel’s Acquisition of Aartee Bright Bar

NorthEdge’s Investment in Cezanne HR

Obsequio Group’s Investment in APS Security & Fire

Brent Council’s Deal With Wates Construction Limited for the Wembley Housing Zone Development

Moore Kingston Smith LLP’s External Investment From Waterland

Virgin Money’s Refinancing of Five UK Hotels

Palisade Real Assets’ Acquisition of Eco2 Management Services Limited

City Developments Limited’s £185 Million Acquisition of Four Student Accomodation

CECO Environmental’s Acquisition of Wakefield Acoustics Ltd

Nostrum Oil & Gas’ Restructuring

Dechert Expands its Fund Formation Practice in London With Addition of Sam Kay

Volterra Fietta announces new lateral hire

<strong>Linklaters expands its Financial Sponsor capability with new appointment</strong>

Grey Wolf Therapeutics’ $49 Million Series B Funding Round

Author: Martina Bellini